An mRNA assay system demonstrates proteasomal-specific degradation contributes to cardiomyopathic phospholamban null mutation

  1. Rohner, E.
  2. Witman, N.
  3. Sohlmer, J.
  4. De Genst, E.
  5. Louch, W.E.
  6. Sahara, M.
  7. Chien, K.R.
Journal:
Molecular Medicine

ISSN: 1528-3658,  1076-1551

Year of publication: 2021

Volume: 27

Issue: 1

Type: Article

DOI: 10.1186/S10020-021-00362-8 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus